Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 1;310(1):84-90.
doi: 10.1111/j.1574-6968.2010.02049.x. Epub 2010 Jun 28.

Fosfomycin suppresses RS-virus-induced Streptococcus pneumoniae and Haemophilus influenzae adhesion to respiratory epithelial cells via the platelet-activating factor receptor

Affiliations

Fosfomycin suppresses RS-virus-induced Streptococcus pneumoniae and Haemophilus influenzae adhesion to respiratory epithelial cells via the platelet-activating factor receptor

Shin-ichi Yokota et al. FEMS Microbiol Lett. .

Abstract

Human respiratory syncytial virus (RSV) sometimes causes acute and severe lower respiratory tract illness in infants and young children. The platelet-activating factor (PAF) receptor, which is a receptor for Streptococcus pneumoniae and Haemophilus influenzae, is upregulated by RSV infection in the pulmonary epithelial cell line A549. Fosfomycin, an antimicrobial agent, significantly suppressed PAF receptor induction by RSV infection at the mRNA and cell surface expression levels. Fosfomycin also suppressed RSV-induced adhesion of fluorescence-labeled S. pneumoniae and H. influenzae cells, as determined by flow cytometry and fluorescence microscopy. The RSV-induced bacterial adhesion was suggested to be host-PAF-receptor and bacterial-phosphocholine mediated. Fosfomycin, which has been shown to exhibit antimicrobial and immunomodulatory activities, was found here to suppress adhesion by disease-causing bacteria. Thus, fosfomycin might prevent secondary bacterial infection during RSV infection.

PubMed Disclaimer

Figures

1
1
Upregulation of the PAF receptor (PAF-r) by RSV infection in A549 cells, as determined by flow cytometry (a). Suppression of RSV-induced PAF-r expression by fosfomycin (b and c). (a) A549 cells were infected with the RSV strain Long at MOI 1. After infection at the time indicated, the cells were collected and then stained with an anti-PAF-r antibody and a phycoerythrin-labeled anti-mouse IgG antibody (thick lines). The stained cells were analyzed by flow cytometry. Thin lines indicate cells stained with an unrelated isotype control antibody instead of the anti-PAF-r antibody. (b) Dose dependence of fosfomycin. Two hours before RSV infection, fosfomycin or PDTC was added at the indicated concentration. After a 24-h infection, the expression levels of the PAF-r were determined by flow cytometry as in (a). PDTC, an NF-κB inhibitor, was used as a control. (c) Fosfomycin treatment schedule. Two hours before, simultaneously with, or 4 or 12 h after RSV infection, fosfomycin was added at a concentration of 100 μg mL−1. After 24 h of infection, the expression level of the PAF-r was analyzed by flow cytometry as in (a).
2
2
Suppression of RSV-induced PAF receptor mRNA expression by fosfomycin (FOM) in A549 cells, as determined by RT-PCR. (a) RT-PCR. Two hours before RSV infection, FOM or PDTC was added to cultured A549 cells. PDTC, an NF-κB inhibitor, was used as a positive control for suppression. The cells were infected with RSV strain Long at MOI 1. Total RNA was isolated from cells collected at the indicated times after infection. PAF receptor mRNA (PAF-r) levels were determined by RT-PCR. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels were determined as controls. (b) Virus titer of RSV. Culture supernatants were collected at 24 h after RSV infection as above. The RSV titer in the culture supernatant was determined by a plaque-forming assay.
3
3
Suppression by fosfomycin (FOM) of RSV-induced adhesion to A549 cells of FITC-labeled Streptococcus pneumoniae (a) and Haemophilus influenzae (b), as determined by flow cytometry. Two hours before RSV infection, FOM (10 or 100 μg mL−1), PAF receptor (PAF-r) antagonist (20 μg mL−1), or anti-PAF-r monoclonal antibody (10 μg mL−1) was added to cultured A549 cells. The cells were infected with RSV strain Long at MOI 1. After a 24-h infection, FITC-labeled bacterial cells were added to the cell monolayer at MOI 10, and incubation was continued at 37°C for 30 min. The adhered labeled bacteria were detected by flow cytometry (black lines). Gray lines indicate cells incubated with unlabeled bacteria. Each experiment was performed in triplicate. The mean fluorescence intensity was estimated and the relative value to the mean fluorescence intensity of RSV-uninfected cells incubated with FITC-labeled bacteria was calculated. Graph presents the mean of relative fluorescence intensity±SD. *Statistically significant (P <0.01) from RSV-infected cells without the addition of any inhibitory agents (none).
4
4
Suppression by fosfomycin (FOM) of RSV-induced adhesion to A549 cells of FITC-labeled Streptococcus pneumoniae adhesion, as observed by fluorescence microscopy. RSV infection, treatment with inhibitors, and incubation with FITC-labeled bacteria were the same as in Fig. 3. Bacteria adhering to the A549 cell monolayer were visualized by fluorescence microscopy. Left photo in each image pair, fluorescence microscopy; right photo, phase-contrast microscopy.
5
5
Effect of fosfomycin (FOM) of RSV-induced adhesion to A549 cells of FITC-labeled Streptococcus pneumoniae cells of strain R6 (a) and its phosphocholine-deficient (PC) mutant, as determined by flow cytometry. Two hours before RSV infection, FOM (100 μg mL−1) was added to cultured A549 cells. The cells were infected with RSV strain Long at MOI 1. After a 24-h infection, FITC-labeled bacterial cells were added to the cell monolayer at MOI 10, and incubation was continued at 37°C for 30 min. The adhered labeled bacteria were detected by flow cytometry (black lines). Gray lines indicate cells incubated with unlabeled bacteria. Each experiment was performed in triplicate. The mean fluorescence intensity was estimated and the relative value to the mean fluorescence intensity of RSV-uninfected cells incubated with FITC-labeled bacteria was calculated. Graph presents the mean of relative fluorescence intensity±SD. *P <0.01.
6
6
Suppression by fosfomycin (FOM) of RSV-induced adhesion to A549 cells of FITC-labeled cells of Streptococcus pneumoniae (strain SR4 and DR22) (a) and Haemophilus influenzae (strain SRI2 and SRI68) (b) clinical isolates, as determined by flow cytometry. Two hours before RSV infection, FOM (100 μg mL−1) or the PAF receptor (PAF-r) antagonist (20 μg mL−1) was added to cultured A549 cells. The cells were infected with RSV strain Long at MOI 1. After a 24-h infection, FITC-labeled bacterial cells were added to the cell monolayer at MOI 10, and incubation was continued at 37°C for 30 min. The adhered labeled bacteria were detected by flow cytometry (black lines). Gray lines indicate cells incubated with unlabeled bacteria. Each experiment was performed in triplicate. The mean fluorescence intensity was estimated and the relative value to the mean fluorescence intensity of RSV-uninfected cells incubated with FITC-labeled bacteria was calculated. Figure shows the mean of relative fluorescence intensity±SD. *Statistically significant (P <0.01) from RSV-infected cells without the addition of any inhibitory agents (none).

Similar articles

Cited by

References

    1. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. (1998) Acute otitis media in children with bronchiolitis. Pediatrics 101: 617–619. - PubMed
    1. Assmann G, Schriewer H. (1985) Choline. Methods in Enzymatic Analysis, Vol. VIII (Bergmeyer H, Bergmeyer J, Grassl M, eds), pp. 106–111. Verlag Chemie, Weinheim.
    1. Avadhanula V, Rodriguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC, Adderson EE. (2006) Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 80: 1629–1636. - PMC - PubMed
    1. Chonmaitree T, Heikkinen T. (2000) Viruses and acute otitis media. Pediatr Infect Dis J 19: 1005–1007. - PubMed
    1. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435–438. - PubMed

Publication types

MeSH terms

Substances